<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16224156</article-id><article-id pub-id-type="pmc">2779279</article-id><article-id pub-id-type="doi">10.3346/jkms.2005.20.5.816</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Hepatitis B Virus Genotype C Prevails Among Chronic Carriers of the Virus in Korea</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bae</surname><given-names>Si Hyun</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>Seung Kew</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Jang</surname><given-names>Jeong Won</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Chang Wook</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Nam</surname><given-names>Soon Woo</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Jong Young</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Boo Sung</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="aff" rid="A2">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Young Min</given-names></name><xref ref-type="aff" rid="A3">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Suzuki</surname><given-names>Seiji</given-names></name><xref ref-type="aff" rid="A4">&#x000a7;</xref></contrib><contrib contrib-type="author"><name><surname>Sugauchi</surname><given-names>Fuminaka</given-names></name><xref ref-type="aff" rid="A4">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Mizokami</surname><given-names>Masashi</given-names></name><xref ref-type="aff" rid="A4">&#x000a7;</xref></contrib></contrib-group><aff id="A1"><label>*</label>Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea.</aff><aff id="A2"><label>&#x02020;</label>WHO Collaborating Center for Reference and Research on Viral Hepatitis, Seoul, Korea.</aff><aff id="A3"><label>&#x02021;</label>Hepatology Center, Bundang Jesaeng General Hospital, Seongnam, Korea.</aff><aff id="A4"><label>&#x000a7;</label>Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.</aff><author-notes><corresp>
Address for correspondence: Masashi Mizokami, M.D. Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. Tel: +81-52-853-8289, Fax: +81-52-842-0021, <email>mizokami@med.nagoya-cu.ac.jp</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2005</year></pub-date><pub-date pub-type="epub"><day>31</day><month>10</month><year>2005</year></pub-date><volume>20</volume><issue>5</issue><fpage>816</fpage><lpage>820</lpage><history><date date-type="received"><day>18</day><month>1</month><year>2005</year></date><date date-type="accepted"><day>03</day><month>5</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2005</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Hepatitis B virus (HBV) is one of the major causative agents of chronic liver diseases in Korea. HBV has been classified into 8 genotypes by a divergence of &#x0003e;8% in the entire genomic sequence, and have distinct geographic distributions. There are limited data on the relevance between HBV genotypes and clinical outcomes in Korea. To investigate the clinical feature relating to HBV genotype in Korea, a total 120 serum samples with HBsAg (65 from Seoul and 55 from the other city in Korea) were obtained from each 30 chronic HBV carriers with asymptomatic carrier (ASC), chronic hepatitis (CH), liver cirrhosis (LC) and hepatocellular carcinoma (HCC). HBV genotype was determined by either enzyme-linked immunosorbent assay (ELISA) using monoclonal antibodies against genotype-specific epitopes in the preS2-region or the direct sequencing of small S gene. HBV genotypes were determined in 105 (87.5%) of 120 samples. HBV genotype C was identified in all HBV carriers with ASC, CH, LC, and HCC. Genotypes A, B, D, E, F and G were not detected in any of them. Genotype C HBV prevails predominantly among chronic carriers of the virus in Korea, irrespective of their clinical stages of liver disease and geographic origin.</p></abstract><kwd-group><kwd>Hepatitis B virus</kwd><kwd>Hepatitis, Chronic</kwd><kwd>Genotype</kwd><kwd>Enzyme-Linked Immunosorbent Assay</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Hepatitis B virus (HBV) is one of the major causative agents of chronic liver diseases, including asymptomatic carrier (ASC), chronic hepatitis (CH), liver cirrhosis (LC) and hepatocellular carcinoma (HCC) (<xref ref-type="bibr" rid="B1">1</xref>). HBV infection is especially prevalent in African and Asian countries such as Korea, Japan, Taiwan and China because most patients with chronic HBV infection have acquired the infection perinatally from carrier mothers (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>).</p><p>Liver injury associated with HBV infection is mediated predominantly through an immune mechanism (<xref ref-type="bibr" rid="B4">4</xref>). This immune response is influenced by age at infection, host genetic factors and the genetic variability of the virus (<xref ref-type="bibr" rid="B5">5</xref>).</p><p>The serological heterogeneity of the hepatitis B surface antigen (HBsAg) has been well established. HBV isolates have been classified into 9 different subtypes according to the antigenic determinants of their HBsAg (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). However, the classification of HBV by serologic subtype is not rational because a single point mutation at the S gene may result in a change in subtype (<xref ref-type="bibr" rid="B8">8</xref>). Therefore, according to the molecular evolutionary analysis of the genomic DNA sequence, HBV strains isolated in various countries are classified into 8 genotypes: genotypes A to H (<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>). It is a distinct trend that the distribution of HBV genotypes throughout the world is specific to location. For example, genotype A is prevalent in the United States, Europe, and Central Africa (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). The incidence of genotype B and C varies markedly among Asian countries (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>).</p><p>Recently, the influences of HBV genotypes in manifestation of clinical liver disease have been reported (<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B21">21</xref>). However, results concerning the distribution of HBV genotypes and the association between the distinct genotypes and the severity of liver disease in Korea remained unreported. A previous comparative study of HBV-associated liver diseases between the southern part of Korea and western part of Japan has shown a difference in severity of liver disease. The HBsAg positive rate of patients with LC and HCC was higher in Korea than in Japan (<xref ref-type="bibr" rid="B22">22</xref>). Moreover, mortality rates of HCC among Koreans were higher than those among Japanese (<xref ref-type="bibr" rid="B23">23</xref>).</p><p>In the present study, we used a monoclonal antibody of the epitopes specific for each HBV genotype and classified the epitopes into five serotypes: <italic>bsu</italic>, <italic>bm</italic>, <italic>bks</italic>, <italic>bksu</italic>, and <italic>bk</italic>, which are equivalent to genotypes A, B, C, D, E, and F respectively. By using this enzyme-linked immunosorbent assay (ELISA), we investigated the prevalence of HBV genotypes and the association between distinct genotypes and the severity of liver disease in Korea.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Patients</title><p>A total of 120 serum samples with positive for HBsAg were obtained from chronic HBV carriers (65 from Seoul and 55 from the other city in Korea) who underwent long-term follow-up at Kangnam St. Mary's Hospital, the Catholic University of Korea, Seoul, Korea. They included 30 asymptomatic HBsAg carriers (ASC, persistently normal serum alanine aminotransferase levels for at least 2 yr in periodic biochemical examinations every 3 or 6 months), 30 CH, 30 LC, and 30 HCC. Chronic hepatitis was diagnosed from liver biopsy samples by sono-guided needle aspiration. Liver cirrhosis was diagnosed by liver function and sonogram. The diagnosis of HCC was established in liver-biopsied specimens, and typical features were noted on angiography. Serum samples from each subject were taken and stored at -80&#x02103; until virological tests were performed. For patients with histologically verified chronic liver disease, serum samples were collected when liver biopsies were performed.</p></sec><sec><title>Serological markers and detection of HBV DNA</title><p>HBsAg and hepatitis B e antigen (HBeAg) were determined by a commercially available kit (Abbott Laboratories, Abbott Park, IL, U.S.A.). Detectable HBV DNA in serum was quantified by Quantiplex branched DNA assay (Bayer Diagnostics, Berkeley, CA, U.S.A.; sensitivity 2.5 pg/mL)</p></sec><sec><title>Serological determination of the six HBV genotypes</title><p>The six major genotypes of HBV, i.e. A, B, C, D, E and F were determined by ELISA with commercial kits (HBV Genotype EIA, Institute of Immunology, Tokyo, Japan) according to the method described by Usuda et al. (<xref ref-type="bibr" rid="B24">24</xref>). First, HBsAg particles in test sera were captured by immobilized antibody to the common determinant of HBsAg. Then, they were subjected to binding with monoclonal antibodies against five distinct preS2 epitopes, designated <italic>b</italic>, <italic>k</italic>, <italic>m</italic>, <italic>s</italic>, and <italic>u</italic>, which were labeled with horseradish peroxidase (HRP). Since the expression of these five epitopes is influenced by HBV genotypes, the combination thereof enables us to determine the genotypes serologically. The epitope <italic>b</italic> is shared by HBsAg of all genotypes. Genotypes A, B, C, D, and F were distinguished by five serotypes recognized by respective mAbs, i.e. <italic>bsu</italic>, <italic>bm</italic>, <italic>bks</italic>, <italic>bksu</italic>, and <italic>bk</italic>. Thus, the serotype bsu is specific for genotype A, <italic>bm</italic> for B, <italic>bks</italic> for C, <italic>bksu</italic> for D, E and <italic>bk</italic> for F. The validity of this ELISA for serological determination of the five HBV genotypes has been verified previously (<xref ref-type="bibr" rid="B24">24</xref>).</p></sec><sec><title>Determination of genotypes by HBV DNA sequences</title><p>HBV genotype in six samples was determined by phylogenetic analysis using the method described previously (<xref ref-type="bibr" rid="B25">25</xref>). Nucleic acids were extracted from 100 &#x000b5;L of serum, using a DNA extractor kit (Genome Science Laboratory, Fukushima, Japan). The entire small S gene (681 bp) was amplified by two overlapping fragments. The PCR primers for the first round consisted of sense: 5'-AAG CTC TGC TAG ATC CCA GAG T-3' (SS1: 18-39) and anti-sense: 5'-CAT ACT TTC CAA TCA ATA GG-3' (SS2: 989-970); the primers for the second round were sense primer SS1, antisense: 5'-GAA ACA TAG AGG TGC CTT GAG CAG-3' (SS3: 557-634) and sense: 5'-TGC TGC TAT GCC TCA TCT T-3' (SS4: 414-433), antisense primer SS2 (<xref ref-type="bibr" rid="B25">25</xref>). Amplified HBV DNA fragments were sequenced directly by the dideoxy method using a Taq Dye-Deoxy Terminator cycle sequencing kit and a fluorescent 3100 DNA sequencer (Applied Biosystems, Foster City, CA, U.S. A.). The primers used for the sequencing were the second set of primers described above for PCR.</p></sec><sec><title>Statistical analysis</title><p>Differences between groups were examined by Student's t-test, Fisher's exact probability test or the Mann-Whitney rank test. A two-tailed <italic>p</italic> value of less than 0.05 was considered to be significant. Data analysis was performed using SPSS software (version 10.0, Chicago, IL, U.S.A).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Clinical features of patients with chronic hepatitis B</title><p>The demographic, virological, and clinical characteristics of the carriers with chronic hepatitis were summarized in <xref ref-type="table" rid="T1">Table 1</xref>. A family history of positive for HBsAg, as determined through an interview during the first visit, was noted in 76 patients (63%). Incidence of alcohol consumption, operation and transfusion history was present in 48 (40%), 34 (28%), and 10 (8%) carriers, respectively. HBeAg and HBV DNA were detected in 47 (39%) and 58 (48%) carriers, respectively. Clinical backgrounds in carriers with different stages of liver disease are shown in <xref ref-type="table" rid="T1">Table 1</xref>. In each group, no statistically significant differences were observed between family history of HBV infection and history of transfusion, operation and drinking. The level of albumin and &#x003b3;-glutamyl transpeptidase was significantly lower in the group of LC and HCC than in other groups (<italic>p</italic>=0.045 and <italic>p</italic>=0.039). The alanine aminotransferase (ALT) levels had tendency to increase in carriers with CH, LC and HCC than that of ASC. The HBeAg positive rate was significantly higher in the carriers with CH and LC than in those with ASC and HCC (<italic>p</italic>=0.001), and the HBV DNA positive rate was significantly higher in the carriers with ASC, CH and LC than in those with of HCC (<italic>p</italic>=0.032).</p></sec><sec><title>Distribution of HBV genotypes in 120 patients with chronic hepatitis B</title><p>HBV genotypes were determined by ELISA with monoclonal antibodies against pre S2 determinants. Of the 120 serum samples, 21 (17.5%) were negative for ELISA. Among them, HBV DNA was amplified in 6 samples, and HBV genotypes were determined by direct sequencing of the small S gene (<xref ref-type="table" rid="T2">Table 2</xref>). Finally, the 105 patients (26 ASC, 30 CH, 30 LC and 19 HCC) were analyzed the genotypes of HBV (<xref ref-type="table" rid="T3">Table 3</xref>). HBV genotype C was identified all of the carriers with ASC, CH, LC and HCC. Genotypes A, B, D, E and F were not detected in any of them. All HBV carriers in Seoul and the other cities had genotype C.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>HBV strains isolated in various countries are classified into 8 genotypes: genotypes A to H (<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>). These genotypes are recognized as distinct if differences of more than 8% exist in the entire nucleotide sequence of approximately 3,200 nt. The preS2-region has less constraint on the sequence and would be more variable than the S gene, making it a better candidate than the S gene as the basis of genotypic divergence. With such a rationale, epitopes on the preS2-region product which would reflect genotypes were selected. Monoclonal antibodies which recognized epitopes borne by the preS2-region product were obtained. The present study used an ELISA method to classify HBV genotypes (<xref ref-type="bibr" rid="B24">24</xref>). ELISA is a rather simple method and takes only a short time (about 6 hr), although genotypes are currently determined by restriction fragment length polymorphism (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B26">26</xref>). With the methods in this study, it was possible to classify HBV into five types: HBV genotypes A, B, C, D, E and F based on a combination of epitopes detected with monoclonal antibodies, for example, a common epitope observed on all HBV genotypes, and a specific epitope on the respective HBV genotype.</p><p>It is a distinct feature that the distribution of HBV genotype throughout the world is specific to geographical location. Genotype A is prevalent in the United States, Europe, and Central Africa (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Genotype B and C are frequent in Asia, especially Southeast Asia and Far East Asia (<xref ref-type="bibr" rid="B21">21</xref>), and D is prevalent worldwide, with particular presence in the Mediterranean area, Central Asia, and South America. Genotype E is restricted to West Africa, and genotype F prevails in Central and South America (<xref ref-type="bibr" rid="B27">27</xref>). Genotype G was determined very recently in France and Georgia of the U.S.A., and its distribution is yet to be investigated (<xref ref-type="bibr" rid="B10">10</xref>).</p><p>The incidence of genotype C varies markedly among Asian countries (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B21">21</xref>). In our study, we found that all 105 (100%) patients were HBV genotype C regardless of disease severity in Korean and the outcome of this study is comparable with the results of previous studies in Korea (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). As in the results from Shanghai, China and Japan, genotype C was found in most patients with chronic HBV infection in Korea. As a note of comparison, genotype B was predominant in Taiwan. Genotype C was especially predominant in the central regions of Japan, reaching a distribution of over 95% comparable to that in Korea, suggesting the migration from other Asian countries to the Japanese archipelago. It was reported that people from Northeast Asia migrated to Japan via the Korean peninsula about 2,300 yr ago, displacing the people to the south and north (<xref ref-type="bibr" rid="B30">30</xref>). Besides epidemiological distributions, HBV genotypes would also be able to trace the population movement; the route of infection is mainly found from mother-to-infant perinatally in Asian countries (<xref ref-type="bibr" rid="B31">31</xref>), suggesting that the HBV genotype may be highly conserved in the same population by vertical transmission from mother to baby, especially in Southeast Asia, including Korea. There were significant differences reported regarding geographic distribution; genotypes C and B were predominant in Japan, while Korea expressed no difference in geographic distribution between in and around Seoul and Jeju island, which is located far away from the Seoul, but close to Japan (<xref ref-type="bibr" rid="B28">28</xref>) and genotype C prevailed. This study also shows the same result (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="table" rid="T3">3</xref>). The differences between the two close countries can be associated with the route of migration; people from Northeast Asia and Southern Asia migrated to Japan, but the migration to Korea occurred only from Northeast Asia, with some subsequent migration to Japan (<xref ref-type="bibr" rid="B18">18</xref>).</p><p>It has been reported that HBV genotypes exert their influence through a point mutation in the precore region for an HBeAg-minus phenotype, from G to A nucleotide 1896, which is associated with the loss of HBeAg. Li et al. was the first to note that the HBV genome of genotype A had C 1858 and implicate it in a rare HBeAg seroconversion. Patients with genotype A were significantly more likely to be HBeAg-positive at first examination compared with results in patients with genotypes B and C (<xref ref-type="bibr" rid="B32">32</xref>). In contrast, genotype C strains are heterogenous with respect to T or C as nucleotide 1858 mutations in the HBV genome were associated with HBeAg as well as viral replication (<xref ref-type="bibr" rid="B33">33</xref>). The G1896A mutation changes a wobble G-T for a Watson-Crick A-T pair in genomes with T1585, although it is precluded in those with C1858 because it results in a forbidden C-A pair. In addition, core mutants were more frequent in genotype C strains and were associated with more inflammation and fibrosis of the liver than those in genotype B (<xref ref-type="bibr" rid="B34">34</xref>). These findings suggest that pathogenic differences between genotypes may exist and the core mutation may be useful as a marker for progressive liver damage. Patients with genotype C appeared to be correlated with lower seroconversion rates, severe liver damage, higher replicative activity and more-severe liver inflammation than those with genotype B (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B34">34</xref>).</p><p>Cirrhosis was ascribed to HBV (58%), alcohol (26%), hepatitis C virus (11%) or both (2%), or was cryptogenic (3%) in Korea (<xref ref-type="bibr" rid="B35">35</xref>). HCC is a major public health problem in Korea, where it is the sixth most common cause of death, reported by Korean National Statistical Office in 2002, and is probably linked to the high prevalence of HBV infection (58%) and to the culture which encourages high alcohol consumption. The HBsAg positive rate of patients with liver cirrhosis and HCC was higher in Korea than in Japan (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Mortality rates of HCC among Koreans are also higher than those among Japanese (<xref ref-type="bibr" rid="B23">23</xref>). These may be related to a higher rate of HBsAg carriers, heavy drinking, and the predominance of genotype C in Korea (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Furthermore, low clearance of interferon-induced HBeAg loss in genotype C might be an additional factor of poor prognosis in patients with chronic HBV infection (<xref ref-type="bibr" rid="B38">38</xref>).</p><p>In conclusion, genotype C HBV prevails predominantly among Korean chronic carriers of the virus, irrespective of their clinical stages of liver disease and geographic origin, indicating that it may associate with more advanced liver disease than any other country.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>This study was supported by a research fund from the <funding-source>Catholic Medical Center</funding-source>.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>DS</given-names></name></person-group><article-title>From hepatitis to hepatoma: lessons from type B viral hepatitis</article-title><source>Science</source><year>1993</year><volume>262</volume><fpage>369</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">8211155</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiire</surname><given-names>CF</given-names></name></person-group><collab>The African Regional Study Group</collab><article-title>Hepatitis B infection in sub-Saharan Africa</article-title><source>Vaccine</source><year>1990</year><volume>8</volume><issue>Suppl</issue><fpage>S107</fpage><lpage>S112</lpage><pub-id pub-id-type="pmid">2139278</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Wang</surname><given-names>LY</given-names></name><name><surname>Yu</surname><given-names>MW</given-names></name></person-group><article-title>Epidemiology of hepatitis B virus infection in the Asia-Pacific region</article-title><source>J Gastroenterol Hepatol</source><year>2000</year><volume>15</volume><issue>Suppl</issue><fpage>E3</fpage><lpage>E6</lpage><pub-id pub-id-type="pmid">10921373</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chisari</surname><given-names>FV</given-names></name></person-group><article-title>Cytotoxic T cells and viral hepatitis</article-title><source>J Clin Invest</source><year>1997</year><volume>99</volume><fpage>1472</fpage><lpage>1477</lpage><pub-id pub-id-type="pmid">9119989</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>JY</given-names></name><name><surname>Wright</surname><given-names>TL</given-names></name></person-group><article-title>Molecular virology and pathogenesis of hepatitis B</article-title><source>Lancet</source><year>1993</year><volume>342</volume><fpage>1335</fpage><lpage>1340</lpage><pub-id pub-id-type="pmid">7901639</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishioka</surname><given-names>K</given-names></name><name><surname>Levin</surname><given-names>AG</given-names></name><name><surname>Simons</surname><given-names>MJ</given-names></name></person-group><article-title>Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease</article-title><source>Bull World Health Organ</source><year>1975</year><volume>52</volume><fpage>293</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">1084799</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courouce-Pauty</surname><given-names>AM</given-names></name><name><surname>Lemaire</surname><given-names>JM</given-names></name><name><surname>Roux</surname><given-names>JF</given-names></name></person-group><article-title>New hepatitis B surface antigen subtypes inside the ad category</article-title><source>Vox Sang</source><year>1978</year><volume>35</volume><fpage>304</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">80881</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Imai</surname><given-names>M</given-names></name><name><surname>Tsuda</surname><given-names>F</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Miyakawa</surname><given-names>Y</given-names></name><name><surname>Mayumi</surname><given-names>M</given-names></name></person-group><article-title>Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr</article-title><source>J Virol</source><year>1987</year><volume>61</volume><fpage>3030</fpage><lpage>3034</lpage><pub-id pub-id-type="pmid">3041023</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindh</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>JE</given-names></name><name><surname>Norkrans</surname><given-names>G</given-names></name><name><surname>Horal</surname><given-names>P</given-names></name></person-group><article-title>Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon</article-title><source>J Virol Methods</source><year>1998</year><volume>72</volume><fpage>163</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">9694324</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuyver</surname><given-names>L</given-names></name><name><surname>De Gendt</surname><given-names>S</given-names></name><name><surname>Van Geyt</surname><given-names>C</given-names></name><name><surname>Zoulim</surname><given-names>F</given-names></name><name><surname>Fried</surname><given-names>M</given-names></name><name><surname>Schinazi</surname><given-names>RF</given-names></name><name><surname>Rossau</surname><given-names>R</given-names></name></person-group><article-title>A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness</article-title><source>J Gen Virol</source><year>2000</year><volume>81</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">10640543</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arauz-Ruiz</surname><given-names>P</given-names></name><name><surname>Norder</surname><given-names>H</given-names></name><name><surname>Robertson</surname><given-names>BH</given-names></name><name><surname>Magnius</surname><given-names>LO</given-names></name></person-group><article-title>Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America</article-title><source>J Gen Virol</source><year>2002</year><volume>83</volume><fpage>2059</fpage><lpage>2073</lpage><pub-id pub-id-type="pmid">12124470</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowyer</surname><given-names>SM</given-names></name><name><surname>van Staden</surname><given-names>L</given-names></name><name><surname>Kew</surname><given-names>MC</given-names></name><name><surname>Sim</surname><given-names>JG</given-names></name></person-group><article-title>A unique segment of the hepatitis B virus group A genotype identified in isolates from South Africa</article-title><source>J Gen Virol</source><year>1997</year><volume>78</volume><issue>Pt 7</issue><fpage>1719</fpage><lpage>1729</lpage><pub-id pub-id-type="pmid">9225049</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindh</surname><given-names>M</given-names></name><name><surname>Andersson</surname><given-names>AS</given-names></name><name><surname>Gusdal</surname><given-names>A</given-names></name></person-group><article-title>Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method</article-title><source>J Infect Dis</source><year>1997</year><volume>175</volume><fpage>1285</fpage><lpage>1293</lpage><pub-id pub-id-type="pmid">9180165</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Arase</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Tsubota</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Saitoh</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>F</given-names></name><name><surname>Akuta</surname><given-names>N</given-names></name><name><surname>Someya</surname><given-names>T</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>J</given-names></name><name><surname>Kumada</surname><given-names>H</given-names></name></person-group><article-title>Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C</article-title><source>J Gastroenterol</source><year>2002</year><volume>37</volume><fpage>35</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">11824798</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theamboonlers</surname><given-names>A</given-names></name><name><surname>Tangkijvanich</surname><given-names>P</given-names></name><name><surname>Pramoolsinsap</surname><given-names>C</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name></person-group><article-title>Genotypes and subtypes of hepatitis B virus in Thailand</article-title><source>Southeast Asian J Trop Med Public Health</source><year>1998</year><volume>29</volume><fpage>786</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">10772565</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>PJ</given-names></name><name><surname>Lai</surname><given-names>MY</given-names></name><name><surname>Chen</surname><given-names>DS</given-names></name></person-group><article-title>Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B</article-title><source>Gastroenterology</source><year>2000</year><volume>118</volume><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">10702206</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Mizokami</surname><given-names>M</given-names></name><name><surname>Yao</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Orito</surname><given-names>E</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Nakanishi</surname><given-names>M</given-names></name></person-group><article-title>Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China</article-title><source>Intervirology</source><year>2001</year><volume>44</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">11223719</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orito</surname><given-names>E</given-names></name><name><surname>Ichida</surname><given-names>T</given-names></name><name><surname>Sakugawa</surname><given-names>H</given-names></name><name><surname>Sata</surname><given-names>M</given-names></name><name><surname>Horiike</surname><given-names>N</given-names></name><name><surname>Hino</surname><given-names>K</given-names></name><name><surname>Okita</surname><given-names>K</given-names></name><name><surname>Okanoue</surname><given-names>T</given-names></name><name><surname>Iino</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>E</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Hige</surname><given-names>S</given-names></name><name><surname>Mizokami</surname><given-names>M</given-names></name></person-group><article-title>Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan</article-title><source>Hepatology</source><year>2001</year><volume>34</volume><fpage>590</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">11526547</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orito</surname><given-names>E</given-names></name><name><surname>Mizokami</surname><given-names>M</given-names></name><name><surname>Sakugawa</surname><given-names>H</given-names></name><name><surname>Michitaka</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Ichida</surname><given-names>T</given-names></name><name><surname>Okanoue</surname><given-names>T</given-names></name><name><surname>Yotsuyanagi</surname><given-names>H</given-names></name><name><surname>Iino</surname><given-names>S</given-names></name></person-group><collab>Japan HBV Genotype Research Group</collab><article-title>A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C</article-title><source>Hepatology</source><year>2001</year><volume>33</volume><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">11124839</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujie</surname><given-names>H</given-names></name><name><surname>Moriya</surname><given-names>K</given-names></name><name><surname>Shintani</surname><given-names>Y</given-names></name><name><surname>Yotsuyanagi</surname><given-names>H</given-names></name><name><surname>Iino</surname><given-names>S</given-names></name><name><surname>Koike</surname><given-names>K</given-names></name></person-group><article-title>Hepatitis B virus genotypes and hepatocellular carcinoma in Japan</article-title><source>Gastroenterology</source><year>2001</year><volume>120</volume><fpage>1564</fpage><lpage>1565</lpage><pub-id pub-id-type="pmid">11339239</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsubota</surname><given-names>A</given-names></name><name><surname>Arase</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>F</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Kumada</surname><given-names>H</given-names></name></person-group><article-title>Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw</article-title><source>J Med Virol</source><year>2001</year><volume>65</volume><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">11536231</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haratake</surname><given-names>J</given-names></name><name><surname>Horie</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>SD</given-names></name><name><surname>Jimi</surname><given-names>A</given-names></name><name><surname>Yoshimura</surname><given-names>M</given-names></name></person-group><article-title>A comparative study of HBV-associated liver diseases between Korea and western part of Japan</article-title><source>Gan No Rinsho</source><year>1990</year><volume>Spec No</volume><fpage>313</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">2156093</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyong</surname><given-names>SJ</given-names></name><name><surname>Tsukuma</surname><given-names>H</given-names></name><name><surname>Hiyama</surname><given-names>T</given-names></name></person-group><article-title>Case-control study of hepatocellular carcinoma among Koreans living in Osaka, Japan</article-title><source>Jpn J Cancer Res</source><year>1994</year><volume>85</volume><fpage>674</fpage><lpage>679</lpage><pub-id pub-id-type="pmid">8071108</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usuda</surname><given-names>S</given-names></name><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Iwanari</surname><given-names>H</given-names></name><name><surname>Baba</surname><given-names>K</given-names></name><name><surname>Tsuda</surname><given-names>F</given-names></name><name><surname>Miyakawa</surname><given-names>Y</given-names></name><name><surname>Mayumi</surname><given-names>M</given-names></name></person-group><article-title>Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product</article-title><source>J Virol Methods</source><year>1999</year><volume>80</volume><fpage>97</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">10403681</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugauchi</surname><given-names>F</given-names></name><name><surname>Mizokami</surname><given-names>M</given-names></name><name><surname>Orito</surname><given-names>E</given-names></name><name><surname>Ohno</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Butterworth</surname><given-names>LA</given-names></name><name><surname>Cooksley</surname><given-names>WG</given-names></name></person-group><article-title>A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness</article-title><source>J Gen Virol</source><year>2001</year><volume>82</volume><fpage>883</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">11257194</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizokami</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Orito</surname><given-names>E</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Sakugawa</surname><given-names>H</given-names></name><name><surname>Mukaide</surname><given-names>M</given-names></name><name><surname>Robertson</surname><given-names>BH</given-names></name></person-group><article-title>Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns</article-title><source>FEBS Lett</source><year>1999</year><volume>450</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">10350059</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arauz-Ruiz</surname><given-names>P</given-names></name><name><surname>Norder</surname><given-names>H</given-names></name><name><surname>Visona</surname><given-names>KA</given-names></name><name><surname>Magnius</surname><given-names>LO</given-names></name></person-group><article-title>Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry the precore stop mutant</article-title><source>J Med Virol</source><year>1997</year><volume>51</volume><fpage>305</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">9093945</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Yeom</surname><given-names>JJ</given-names></name><name><surname>Kim</surname><given-names>HC</given-names></name><name><surname>Moon</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>JS</given-names></name></person-group><article-title>Genotypes of hepatitis B virus on Jeju island</article-title><source>Korean J Hepatol</source><year>2004</year><volume>10</volume><fpage>42</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15096716</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>BC</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Cha</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>SM</given-names></name></person-group><article-title>Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea</article-title><source>J Hepatol</source><year>2003</year><volume>38</volume><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">12480566</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horai</surname><given-names>S</given-names></name><name><surname>Murayama</surname><given-names>K</given-names></name><name><surname>Hayasaka</surname><given-names>K</given-names></name><name><surname>Matsubayashi</surname><given-names>S</given-names></name><name><surname>Hattori</surname><given-names>Y</given-names></name><name><surname>Fucharoen</surname><given-names>G</given-names></name><name><surname>Harihara</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Omoto</surname><given-names>K</given-names></name><name><surname>Pan</surname><given-names>IH</given-names></name></person-group><article-title>mtDNA polymorphism in East Asian Populations, with special reference to the peopling of Japan</article-title><source>Am J Hum Genet</source><year>1996</year><volume>59</volume><fpage>579</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">8751859</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lok</surname><given-names>AS</given-names></name></person-group><article-title>Natural history and control of perinatally acquired hepatitis B virus infection</article-title><source>Dig Dis</source><year>1992</year><volume>10</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">1551246</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JS</given-names></name><name><surname>Tong</surname><given-names>SP</given-names></name><name><surname>Wen</surname><given-names>YM</given-names></name><name><surname>Vitvitski</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Trepo</surname><given-names>C</given-names></name></person-group><article-title>Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region</article-title><source>J Virol</source><year>1993</year><volume>67</volume><fpage>5402</fpage><lpage>5410</lpage><pub-id pub-id-type="pmid">8350403</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckwold</surname><given-names>VE</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Yen</surname><given-names>TS</given-names></name><name><surname>Ou</surname><given-names>JH</given-names></name></person-group><article-title>Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication</article-title><source>J Virol</source><year>1996</year><volume>70</volume><fpage>5845</fpage><lpage>5851</lpage><pub-id pub-id-type="pmid">8709203</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindh</surname><given-names>M</given-names></name><name><surname>Hannoun</surname><given-names>C</given-names></name><name><surname>Dhillon</surname><given-names>AP</given-names></name><name><surname>Norkrans</surname><given-names>G</given-names></name><name><surname>Horal</surname><given-names>P</given-names></name></person-group><article-title>Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers</article-title><source>J Infect Dis</source><year>1999</year><volume>179</volume><fpage>775</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">10068571</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Um</surname><given-names>SH</given-names></name><name><surname>Ryu</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>JB</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Park</surname><given-names>DK</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Jin</surname><given-names>YT</given-names></name><name><surname>Chun</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>CD</given-names></name><name><surname>Hyun</surname><given-names>JH</given-names></name></person-group><article-title>The prognosis of liver cirrhosis in recent years in Korea</article-title><source>J Korean Med Sci</source><year>2003</year><volume>18</volume><fpage>833</fpage><lpage>841</lpage><pub-id pub-id-type="pmid">14676440</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SD</given-names></name></person-group><article-title>A serological survey and histopathological comparison of HBV-associated liver diseases in southern part of Korea and west Japan</article-title><source>J Uoeh</source><year>1989</year><volume>11</volume><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">2549603</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SC</given-names></name><name><surname>Oh</surname><given-names>SI</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name></person-group><article-title>Korean status of alcoholics and alcoholrelated health problems</article-title><source>Alcohol Clin Exp Res</source><year>1998</year><volume>22</volume><fpage>170S</fpage><lpage>172S</lpage><pub-id pub-id-type="pmid">9622398</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wai</surname><given-names>CT</given-names></name><name><surname>Chu</surname><given-names>CJ</given-names></name><name><surname>Hussain</surname><given-names>M</given-names></name><name><surname>Lok</surname><given-names>AS</given-names></name></person-group><article-title>HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C</article-title><source>Hepatology</source><year>2002</year><volume>36</volume><fpage>1425</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">12447868</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical characteristics of 120 HBsAg carriers with different stages of liver disease</p></caption><graphic xlink:href="jkms-20-816-i001"/><table-wrap-foot><fn><p>ASC, asymptomatic carriers; CH, chronic hepatitis; LC, liver cirrhosis; HCC, hepatocellular carcinoma; ALT, alanine aminotransferase; &#x003b3;-GTP, &#x003b3;-glutamyl transpeptidase; <sup>*</sup><italic>p</italic>=0.045; <sup>&#x02020;</sup><italic>p</italic>=0.039; <sup>&#x02021;</sup><italic>p</italic>=0.001; <sup>&#x000a7;</sup><italic>p</italic>=0.032.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>HBV genotype as determined by ELISA and direct sequencing (n=105)</p></caption><graphic xlink:href="jkms-20-816-i002"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Distribution of HBV genotype in 105 HBsAg carriers with different stages of liver disease</p></caption><graphic xlink:href="jkms-20-816-i003"/><table-wrap-foot><fn><p>ASC, asymptomatic carriers; CH, chronic hepatitis; LC, liver cirrhosis; HCC, hepatocellular carcinoma.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
